RAPID-Net: Accurate Pocket Identification for Binding-Site-Agnostic Docking
Yaroslav Balytskyi1, Inna Hubenko2, Alina Balytska2
1Department of Physics and Astronomy, Wayne State University, Detroit, Michigan 48201, United States.
Abstract:
Accurate identification of druggable pockets and their features is essential for structure-based drug design and effective downstream docking. Here, we present RAPID-Net, a deep learning-based algorithm designed for accurate prediction of binding pockets and seamless integration with docking pipelines. On the PoseBusters benchmark, RAPID-Net-guided AutoDock Vina achieves 54.9% of Top-1 poses with RMSD < 2 Å and satisfying the PoseBusters chemical-validity criterion, compared to 49.1% for DiffBindFR. On the most challenging time split of PoseBusters, aiming to assess generalization ability (structures submitted after September 30, 2021), RAPID-Net-guided AutoDock Vina achieves 53.1% of Top-1 poses with RMSD < 2 Å and PB-valid, versus 59.5% for AlphaFold 3. Notably, in 92.2% of cases, RAPID-Net-guided Vina samples at least one pose with RMSD < 2 Å (regardless of its rank), indicating that pose ranking, rather than sampling, is the primary accuracy bottleneck. The lightweight inference, scalability, and competitive accuracy of RAPID-Net position it as a viable option for large-scale virtual screening campaigns. Across diverse benchmark data sets, it outperforms other pocket prediction tools, including PUResNet and Kalasanty, in both docking accuracy and pocket-ligand intersection rates. Furthermore, we demonstrate its potential to accelerate the development of novel therapeutics by highlighting its performance on pharmacologically relevant targets. The model accurately identifies distal functional sites, offering new opportunities for allosteric inhibitor design. In the case of the RNA-dependent RNA polymerase of SARS-CoV-2, RAPID-Net uncovers a wider array of potential binding pockets than existing predictors, which typically annotate only the orthosteric pocket and overlook secondary cavities.
More Related Videos
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Related Concept Videos
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
The Equilibrium Binding Constant and Binding Strength
Protein-protein Interfaces
